Investors Alley's Eddy Elfenbein highlights three drug plays that could benefit from the Covid-19 Outbreak
Bret Jensen
15 hours ago
Investors Alley's Jay Soloff discusses a huge option play on a uranium concern
Feb 18, 2020
A 'sum of the parts' analysis and valuation of Amazon is provided in the paragraphs below
Jan 13, 2020
Investors Alley's Jay Soloff talks about the semiconductor space in 2020 and one possible trade on AMD
Jan 2, 2020
Investors Alley Eddy Elfenbein explains why he prefers one tech workhorse to a current biotech 'lottery ticket'
Jan 1, 2020
Investors Alley's Jay Soloff highlights a bullish bet on a small cap transportation concern
Dec 22, 2019
Investor's Alley Ian Cooper discusses why the big rally in Fate Therapeutics may continue in 2020
Options Expert Jay Soloff takes a look at the direction of interest rates in 2020 and one option trade around that
Dec 12, 2019
Investors Alley Eddy Elfenbein has three healthcare stocks that should be sold immediately due to overvaluation
Dec 11, 2019
Options expert Jay Soloff examines how one trader is positioning for another market crack this December
Dec 5, 2019
Mar 26, 2020
Good piece on what we know so far about Covid19 and what we don't. …
Mar 13, 2020
Good piece on the push back on the initial pricing of two sickle cell disease drugs.
Mar 9, 2020
Very solid synopsis of nine biotech companies working on Covid-19 vaccines
Mar 2, 2020
Good piece on Gilead's acquisition strategy post their $4.9B buyout of FTSV
Feb 14, 2020
Solid piece on 10 potential emerging blockbuster drugs in 2020
Feb 13, 2020
Good piece exploring whether the recent signs of a turnaround at Teva Pharmaceuticals are real....
Feb 4, 2020
Interesting piece on potentially a new target in Alzheimer's research…
Feb 1, 2020
Good piece on the amazing launch of Trikafta for Vertex Pharmaceuticals https://www.biopharmadi...
Jan 17, 2020
Good piece on how Lilly plans to put money to work on the M&A front in 2020.https://endpts.com/...
Jan 12, 2020
Will Dermira be the first of many buyouts across the biotech industry in 2020. Article discuss...
